Cargando…
Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF‐κB activation
Severe acute respiratory syndrome (SARS) is characterized by rapidly progressing respiratory failure resembling acute/adult respiratory distress syndrome (ARDS) associated with uncontrolled inflammatory responses. Here, we demonstrated that, among five accessory proteins of SARS coronavirus (SARS‐Co...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094718/ https://www.ncbi.nlm.nih.gov/pubmed/17141229 http://dx.doi.org/10.1016/j.febslet.2006.11.046 |
_version_ | 1783510527872335872 |
---|---|
author | Kanzawa, Noriyuki Nishigaki, Kazuo Hayashi, Takaya Ishii, Yuichi Furukawa, Souichi Niiro, Ayako Yasui, Fumihiko Kohara, Michinori Morita, Kouichi Matsushima, Kouji Le, Mai Quynh Masuda, Takao Kannagi, Mari |
author_facet | Kanzawa, Noriyuki Nishigaki, Kazuo Hayashi, Takaya Ishii, Yuichi Furukawa, Souichi Niiro, Ayako Yasui, Fumihiko Kohara, Michinori Morita, Kouichi Matsushima, Kouji Le, Mai Quynh Masuda, Takao Kannagi, Mari |
author_sort | Kanzawa, Noriyuki |
collection | PubMed |
description | Severe acute respiratory syndrome (SARS) is characterized by rapidly progressing respiratory failure resembling acute/adult respiratory distress syndrome (ARDS) associated with uncontrolled inflammatory responses. Here, we demonstrated that, among five accessory proteins of SARS coronavirus (SARS‐CoV) tested, 3a/X1 and 7a/X4 were capable of activating nuclear factor kappa B (NF‐κB) and c‐Jun N‐terminal kinase (JNK), and significantly enhanced interleukin 8 (IL‐8) promoter activity. Furthermore, 3a/X1 and 7a/X4 expression in A549 cells enhanced production of inflammatory chemokines that were known to be up‐regulated in SARS‐CoV infection. Our results suggest potential involvement of 3a/X1 and 7a/X4 proteins in the pathological inflammatory responses in SARS. |
format | Online Article Text |
id | pubmed-7094718 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2006 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-70947182020-03-25 Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF‐κB activation Kanzawa, Noriyuki Nishigaki, Kazuo Hayashi, Takaya Ishii, Yuichi Furukawa, Souichi Niiro, Ayako Yasui, Fumihiko Kohara, Michinori Morita, Kouichi Matsushima, Kouji Le, Mai Quynh Masuda, Takao Kannagi, Mari FEBS Lett Short Communications Severe acute respiratory syndrome (SARS) is characterized by rapidly progressing respiratory failure resembling acute/adult respiratory distress syndrome (ARDS) associated with uncontrolled inflammatory responses. Here, we demonstrated that, among five accessory proteins of SARS coronavirus (SARS‐CoV) tested, 3a/X1 and 7a/X4 were capable of activating nuclear factor kappa B (NF‐κB) and c‐Jun N‐terminal kinase (JNK), and significantly enhanced interleukin 8 (IL‐8) promoter activity. Furthermore, 3a/X1 and 7a/X4 expression in A549 cells enhanced production of inflammatory chemokines that were known to be up‐regulated in SARS‐CoV infection. Our results suggest potential involvement of 3a/X1 and 7a/X4 proteins in the pathological inflammatory responses in SARS. John Wiley and Sons Inc. 2006-12-22 2006-11-27 /pmc/articles/PMC7094718/ /pubmed/17141229 http://dx.doi.org/10.1016/j.febslet.2006.11.046 Text en FEBS Letters 580 (2006) 1873-3468 © 2015 Federation of European Biochemical Societies This article is being made freely available through PubMed Central as part of the COVID-19 public health emergency response. It can be used for unrestricted research re-use and analysis in any form or by any means with acknowledgement of the original source, for the duration of the public health emergency. |
spellingShingle | Short Communications Kanzawa, Noriyuki Nishigaki, Kazuo Hayashi, Takaya Ishii, Yuichi Furukawa, Souichi Niiro, Ayako Yasui, Fumihiko Kohara, Michinori Morita, Kouichi Matsushima, Kouji Le, Mai Quynh Masuda, Takao Kannagi, Mari Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF‐κB activation |
title | Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF‐κB activation |
title_full | Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF‐κB activation |
title_fullStr | Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF‐κB activation |
title_full_unstemmed | Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF‐κB activation |
title_short | Augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/X1 and 7a/X4 proteins through NF‐κB activation |
title_sort | augmentation of chemokine production by severe acute respiratory syndrome coronavirus 3a/x1 and 7a/x4 proteins through nf‐κb activation |
topic | Short Communications |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7094718/ https://www.ncbi.nlm.nih.gov/pubmed/17141229 http://dx.doi.org/10.1016/j.febslet.2006.11.046 |
work_keys_str_mv | AT kanzawanoriyuki augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation AT nishigakikazuo augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation AT hayashitakaya augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation AT ishiiyuichi augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation AT furukawasouichi augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation AT niiroayako augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation AT yasuifumihiko augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation AT koharamichinori augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation AT moritakouichi augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation AT matsushimakouji augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation AT lemaiquynh augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation AT masudatakao augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation AT kannagimari augmentationofchemokineproductionbysevereacuterespiratorysyndromecoronavirus3ax1and7ax4proteinsthroughnfkbactivation |